Allergies News and Research

Latest Allergies News and Research

Fluorescent protein tool may speed identification of molecular changes that reveal cells' inner workings

Scientists at Johns Hopkins and the University of Texas Medical Branch have created a new tool that easily reveals when and where a key cellular signal is active.

16 Nov 2004

Vaccine provides new hope to the millions of people who suffer from food allergies

A team led by a researcher at the Stanford University School of Medicine has developed vaccines that vastly reduce or eliminate dogs' allergic reactions to three major food allergens: peanuts, milk and wheat. The vaccines' benefits lasted at least three months.

14 Nov 2004

Kids who outgrow peanut allergy need to eat peanut products at least once a month in order to maintain tolerance

Kids who outgrow peanut allergy have a slight chance of recurrence, but researchers from the Johns Hopkins Children's Center report that the risk is much lower in children who frequently eat peanuts or peanut products.

11 Nov 2004

Sex genes of infectious fungus closely resemble human Y chromosome

Fungi and animals, including humans, have a lot in common when it comes to the arrangement of genes that determine their sex, according to new work by Howard Hughes Medical Institute geneticists at the Duke University Medical Center.

10 Nov 2004

ACE inhibitors not needed for many heart disease patients

Many heart disease patients who are already receiving state-of-the-art therapy do not benefit from additional treatment with angiotensin converting enzyme (ACE) inhibitors, according to results of a new study funded by the National Heart, Lung, and Blood Institute (NHLBI).

8 Nov 2004

VaxGen gets $877.5 million to supply 75 million doses of anthrax vaccine

VaxGen announced today that the U.S. government has awarded the company an $877.5 million contract to supply 75 million doses of anthrax vaccine for civilian defense.

4 Nov 2004

Vaccine contributions to health highlighted at PAHO meeting

Vaccine programs in the Americas have made major contributions to improving health in the Americas and new vaccines could go even further, said Dr. D.A. Henderson, a global expert who chairs a Pan American Health Organization (PAHO) technical group here today.

4 Nov 2004

New understanding of the role viruses play in the development of autoimmune diseases

Researchers at the La Jolla Institute for Allergy & Immunology have added a significant milestone to scientific understanding of the role viruses play in the development of autoimmune diseases, such as diabetes.

4 Nov 2004

Study of infection prevention therapy for premature babies

Whether donated human antibodies can protect premature babies from a common and potentially dangerous bacterial infection is under study at the Medical College of Georgia Children’s Medical Center.

4 Nov 2004

Study shows possible solution to the current flu vaccine shortage

A new study led by the Saint Louis University’s Center for Vaccine Development may provide a solution to the current flu vaccine shortage in the U.S. The team found a possible way to double the available supply of influenza vaccine for adults between the ages of 18 and 60.

4 Nov 2004

Some allergic conditions could increase your risk of suffering from blood cancer

Some allergic conditions could increase your risk of suffering from blood cancer as an adult, according to a new study published in the November 2004 issue of BMC Public Health. This is important news for the increasingly large numbers of allergy sufferers worldwide.

4 Nov 2004

$73 million to tackle infectious diseases such as West Nile virus and influenza

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded 14 contracts totaling more than $73 million to fund the Large-Scale Antibody and T Cell Epitope Discovery Program, an initiative aimed at quickly identifying the regions of selected infectious agents that elicit immune reactions.

1 Nov 2004

New vaccines to counter biological agents such as anthrax

Scientists at Imperial College London and Hammersmith Hospital are to help develop new vaccines in case of a terrorist release of biological agents such as anthrax.

1 Nov 2004

Study results suggest that metronidazole and clindamycin differ in their effects on microbes in women with bacterial vaginosis

In the first study to directly compare the emergence of antibiotic resistance following topical treatment between two antibiotics routinely prescribed for a common vaginal infection, researchers from the Magee-Womens Research Institute have found antibiotic-resistant bacteria more likely to develop with the drug clindamycin than metronidazole.

1 Nov 2004

Cellular enzyme represents a potential new target for developing improved HIV drugs

Scientists have discovered that a cellular enzyme helps ferry HIV genetic instructions out of the cell nucleus where they can then be translated into proteins to begin their most destructive work.

1 Nov 2004

FDA warns of risks associated with using decorative contact lenses

This Halloween season, the U.S. Food and Drug Administration (FDA) is again warning consumers about the serious risks of using decorative contact lenses distributed without appropriate involvement by an eye care professional.

29 Oct 2004

New molecular tool to pinpoint DNA mutations among thousands of cells

Scientists have designed a new molecular tool, dubbed "LigAmp," to pinpoint DNA mutations among thousands of cells, the equivalent of searching for a single typo in an entire library of books.

28 Oct 2004

Umbilical cord blood may hold clue to childhood allergy and asthma

High levels of antibodies to allergens in a baby's umbilical cord blood might be more important in the development of childhood allergies and asthma than exposure to allergens, or lack of them, after birth, suggests research in Thorax.

28 Oct 2004

Radiotherapy with cetuximab significantly improves disease control and survival in head and neck cancer

Combination treatment using the monoclonal antibody cetuximab, along with high dose radiotherapy in the treatment of patients with loco-regionally advanced squamous cell carcinoma of the head and neck results in significant improvements in both loco-regional control and overall survival, according to Dr Jordi Giralt of Val d'Hebron University Hospital.

26 Oct 2004

Who should and who should not get a flu shot?

This year's supply of flu vaccine is limited. It is important that people at highest risk of serious illness or death from the flu get a flu shot. Complete this CDC form to see if you or your child should or should not get a flu shot.

25 Oct 2004

Allergies News and Research

Latest Allergies News and Research

Fluorescent protein tool may speed identification of molecular changes that reveal cells' inner workings

Vaccine provides new hope to the millions of people who suffer from food allergies

Kids who outgrow peanut allergy need to eat peanut products at least once a month in order to maintain tolerance

Sex genes of infectious fungus closely resemble human Y chromosome

ACE inhibitors not needed for many heart disease patients

VaxGen gets $877.5 million to supply 75 million doses of anthrax vaccine

Vaccine contributions to health highlighted at PAHO meeting

New understanding of the role viruses play in the development of autoimmune diseases

Study of infection prevention therapy for premature babies

Study shows possible solution to the current flu vaccine shortage

Some allergic conditions could increase your risk of suffering from blood cancer

$73 million to tackle infectious diseases such as West Nile virus and influenza

New vaccines to counter biological agents such as anthrax

Study results suggest that metronidazole and clindamycin differ in their effects on microbes in women with bacterial vaginosis

Cellular enzyme represents a potential new target for developing improved HIV drugs

FDA warns of risks associated with using decorative contact lenses

New molecular tool to pinpoint DNA mutations among thousands of cells

Umbilical cord blood may hold clue to childhood allergy and asthma

Radiotherapy with cetuximab significantly improves disease control and survival in head and neck cancer

Who should and who should not get a flu shot?

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

Allergies News and Research

Latest Allergies News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

Newsletters you may be interested in